Roberts Carmichael 4
4 · Lyra Therapeutics, Inc. · Filed May 6, 2020
Insider Transaction Report
Form 4
Roberts Carmichael
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+415→ 58,414 total - Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−14,318→ 0 total→ Common Stock (415 underlying)
Footnotes (1)
- [F1]Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date.